FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38232711000001107: Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Apr 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1291181000001111 Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1291191000001113 Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Is a Poteligeo true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has specific active ingredient Mogamulizumab false Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Is a Mogamulizumab 20mg/5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Has specific active ingredient Mogamulizumab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) 1 vial Has AMP True Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start